Solesta is an injectable gel that has been developed to be administered in an outpatient setting without the need for anesthesia. The purpose of the product is to expand the submucosal layer of a patient’s anal canal to improve bowel control.
Read the news release about Solesta as an approved fecal incontinence product.
Read other coverage about gastroenterology:
– Allergan Seeks Approval for Lap-Band Surgery for Less Obese Patients
– 3 Ways to Increase Savings for Surgery Center Supplies
– Best Practice: Applying Abdominal Pressure for More Successful Colonoscopy Screenings
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.